- $35.96bn
- $61.12bn
- $20.39bn
- 84
- 62
- 42
- 67
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 9,730 | 9,358 | 15,864 | 33,428 | 20,394 |
Cost of Revenue | |||||
Gross Profit | 4,004 | 4,309 | 1,268 | 6,943 | 17,986 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7,424 | 6,944 | 16,681 | 28,935 | 4,890 |
Operating Profit | 2,306 | 2,414 | -817 | 4,493 | 15,504 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 715 | 544 | -2,278 | 3,094 | 14,578 |
Provision for Income Taxes | |||||
Net Income After Taxes | 1,232 | 501 | -1,565 | 2,635 | 12,059 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 648 | -85 | -2,343 | 1,428 | 9,881 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 648 | -85 | -2,343 | 1,428 | 9,881 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.71 | 0.477 | -8.94 | 5.87 | 40.7 |
Dividends per Share |